Nephros Inc.

3960 Broadway
New York
New York
10032
United States

Tel: 212-781-5113
Fax: 212-781-5166

Email: info@nephros.com

Show jobs for this employer

160 articles with Nephros Inc.

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its third quarter 2020 financial results on Thursday, November 5, 2020 after market close and will host a conference call that same day at 4:30 PM ET, during which management will discuss the

  • Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a registered direct offering of 833,333 shares of common stock at a price to the public of $6.00 per share.  The offering is expected to close on or about Oc

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th – 16th, 2020.

  • Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary financial results for the quarter ended September 30, 2020. Net revenues for the quarter are expected to be $2.1 million, a sequential increase of approximately 34% compared to the prior quarter ended

  • Presentation on Tuesday, September 1 st at 10:20am ET by Nephros, Inc. , today announced that it will be presenting at the LD 500 virtual investor conference on Tuesday, September 1 st at 10:20am ET. Andy Astor, President and Chief Executive Officer of Nephros

  • Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that Andy Astor, currently the company’s Chief Operating Officer and Chief Financial Officer, has been named President and CEO, effective August

  • Nephros, Inc., a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, announced financial results for the three months ended June 30, 2020.

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its second quarter 2020 financial results on Wednesday, August 5, 2020 and will host a conference call that same day at 4:30 PM ET, during which management will discuss the company's financial results and provide

  • Nephros SequaPath™, a new microbial screening system, used to evaluate 88 building water samples across four US geographic regions

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting virtually at the upcoming Zooming with LD event on Thursday, July 23rd at 11:00 AM ET.

  • Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary financial results for the quarter ended June 30, 2020. Net revenues for the quarter are expected to be $1.6 million, a decrease of approximately 33% compared

  • Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it is set to join the Russell Microcap® Index at the conclusion of the 2020 Russell indexes annual reconstitution,

  • Nephros, Inc. (Nasdaq: NEPH ), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting at the upcoming Virtual Summer Summit on Tuesday, June 9 th at 10:55 AM ET. Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from i

  • Nephros, Inc. announced that, due to the public health concerns associated with the ongoing coronavirus outbreak and to support the health and well-being of its stockholders, employees, and other partners, the location of the 2020 Annual Meeting of Stockholders of Nephros, Inc. has been changed.

  • Nephros, Inc., a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, announced financial results for the three months ended March 31, 2020.

  • Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its first quarter 2020 financial results on Wednesday, May 6, 2020 and will host a conference call that same day at 4:30 PM ET, during which management will discuss the company's financial result

  • Anticipates $2.6 Million Net Revenues, Approximately 45% Growth Over 2019

  • Specialty Renal Products, Inc., a subsidiary of Nephros, Inc., a medical device company that develops and sells a hemodiafiltration system for the treatment of patients with end stage renal disease, announced that it has hired Tony Robinson as Vice President of Operations.

  • Nephros, Inc.(Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting at the Sidoti Spring 2020 Investor Conference on Thursday, March 26that 9:10 am EDT. Andy Astor, COO & CFO of Nephros, 

  • Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced financial results for the fourth quarter and full year ended December 31, 2019.